Perceptive Advisors’s Charles River Laboratories CRL Stock Holding History

Perceptive Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.8M	Buy	+140,000	New	+$24.9M	0.48%	46
2025 Q3	–	Sell	-100,000	Closed	-$15.2M	–	95
2025 Q2	$15.2M	Buy	+100,000	New	+$13.3M	0.56%	43
2016 Q4	–	Sell	-5,482	Closed	-$457K	–	193
2016 Q3	$457K	Hold	5,482	–	–	0.03%	135
2016 Q2	$452K	Sell	5,482 -762	-12%	-$62.8K	0.03%	128
2016 Q1	$474K	Buy	6,244 +2,834	+83%	+$210K	0.04%	135
2015 Q4	$274K	Buy	+3,410	New	+$246K	0.02%	111
2014 Q4	–	Sell	-1,860	Closed	-$111K	–	155
2014 Q3	$111K	Hold	1,860	–	–	0.01%	112
2014 Q2	$100K	Buy	+1,860	New	+$102K	0.01%	107

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Perceptive Advisors's CRL Position: Q2 2026 in Review

Perceptive Advisors opened a new position in Charles River Laboratories (CRL) in Q2 2026: 140,000 shares worth $31.8M. The stake represents 0.48% of the portfolio and ranks #46 among its holdings. This is a return to the name: Perceptive Advisors previously reported a position in CRL as recently as Q2 2025.

Perceptive Advisors first reported a position in CRL in Q2 2014 and has held it in 8 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Perceptive Advisors held 140,000 shares of Charles River Laboratories worth $31.8M as of Q2 2026.
Charles River Laboratories was a new Perceptive Advisors position in Q2 2026.
Charles River Laboratories made up 0.48% of Perceptive Advisors's portfolio in Q2 2026, its #46 holding.
Perceptive Advisors first reported a position in Charles River Laboratories in Q2 2014 and has held it in 8 quarters since.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.